Business Context and Reporting Period
Company: The Clorox Company (CLX)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended September 30, 2025 (Fiscal Q1 2026)
Business Overview: A leading multinational manufacturer of consumer and professional products including cleaning, disinfecting, household, lifestyle, and international brands. The company is currently in the stabilization phase of a major Enterprise Resource Planning (ERP) system transition.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2026 (Current) | Q1 2025 (Prior) |
|---|---|---|
| Net Sales | $1,429 | $1,762 |
| Gross Profit | $596 | $807 |
| Gross Margin | 41.7% | 45.8% |
| Net Earnings (Attributable to Clorox) | $80 | $99 |
| Diluted EPS | $0.65 | $0.80 |
| Operating Cash Flow | $93 | $221 |
| Total Debt (Current + Long-term) | $2,703 | $2,488 |
| Cash and Equivalents | $166 | $207 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 19% year-over-year. Organic sales growth was down 17%, driven primarily by lower shipments following incremental stockpiling related to the ERP transition in the prior year's fourth quarter.
- Margin Compression: Gross margin declined 410 basis points to 41.7%, attributed to lower volume and higher manufacturing and logistics costs, partially offset by cost savings.
- Divestiture Impact: The prior period included a $118 million loss on the divestiture of the Better Health VMS business, which is absent in the current period. This significantly impacted the prior year's effective tax rate (41.8% vs. 23.4% currently).
- Segment Performance: All reportable segments saw declines in sales and adjusted EBIT. Health and Wellness sales fell 19%, Household 19%, and Lifestyle 23%. International sales were relatively flat, down 2%.
- Working Capital: Operating cash flow decreased significantly ($93M vs $221M) due to lower cash earnings and changes in working capital, specifically lower receivables and higher inventories resulting from the ERP-related shipment timing.
Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management anticipates a volatile operating environment due to macroeconomic uncertainty, inflationary pressures, and geopolitical instability. The company remains on track to complete its ERP implementation in fiscal year 2026, with total incremental transformational investment expected to be approximately $580 million. The company expects to continue investing in brands and capabilities to deliver profitable growth.
Key Risks and Contingencies
- ERP Transition: Ongoing stabilization of the new ERP system has caused sales timing impacts and incremental costs ($32M in Q1).
- Venture Agreement Obligation: The company has a venture agreement with P&G for the Glad business expiring in January 2026. Clorox is required to purchase P&G's 20% interest for cash at fair value. As of September 30, 2025, the estimated fair value of this obligation is $476 million, recorded as a current liability.
- Liquidity Position: Current liabilities exceeded current assets by $539 million, primarily due to the Glad venture obligation. Management asserts strong liquidity via operating cash flows and access to capital markets ($1.2B credit facility available).
- Environmental Liabilities: Recorded liabilities of $27 million for environmental remediation, with potential additional costs up to $28 million for a specific California site if regulators require extended actions.
Investor Verification Checklist
- ERP Implementation Status: Verify the timeline for full ERP stabilization and the remaining portion of the $580 million transformational investment.
- Glad Venture Buyout: Confirm the final valuation and funding strategy for the $476 million P&G interest buyout due in January 2026.
- Volume Recovery: Monitor subsequent quarters for the normalization of sales volumes following the ERP-related shipment distortions.
- Margin Trajectory: Assess whether gross margin improvements can be achieved despite elevated logistics and manufacturing costs.
- Debt Servicing: Review the impact of rising interest rates on the $2.7 billion total debt load and the company's ability to maintain its 4.0x interest coverage covenant.